Upregulation of additional immune checkpoints including lymphocyte-activation gene 3 (LAG-3) has been seen in multiple cancers including cervical cancer and is thought to play a role in adaptive resistance to ICI [80,81]. This evidence concerns the gene LAG3 and cervical carcinoma.